HALO
NASDAQ · Biotechnology
Halozyme Therapeutics Inc
$111.45
-1.00 (-0.89%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+42.37%
YTD
+58.51%
Open$112.80
Previous Close$112.45
Day High$113.47
Day Low$111.05
52W High$111.15
52W Low$61.23
Volume—
Avg Volume1.43M
Market Cap12.70B
P/E Ratio30.70
EPS$3.35
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$71.23
Above
SMA 200
$65.75
Above
RSI (14)
47.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
-81.1% upside
Current
$111.45
$111.45
Target
$21.02
$21.02
$15.29
$21.02 avg
$24.22
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.27B | 991.28M | 1.30B |
| Net Income | 288.75M | 202.43M | -74,995,325 |
| Profit Margin | 22.7% | 21.6% | -5.8% |
| EBITDA | 492.23M | 364.25M | -91,476,031 |
| Free Cash Flow | — | — | -86,399,966 |
| Rev Growth | +28.4% | +28.4% | +13.4% |
| Debt/Equity | 43.89 | 43.89 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |